Home/Filings/4/0001415889-22-010913
4//SEC Filing

Bushman Julie L 4

Accession 0001415889-22-010913

CIK 0000842023other

Filed

Oct 30, 8:00 PM ET

Accepted

Oct 31, 5:19 PM ET

Size

10.8 KB

Accession

0001415889-22-010913

Insider Transaction Report

Form 4
Period: 2022-10-27
Transactions
  • Award

    Common Stock

    2022-10-27+3381,012 total
  • Award

    Stock Options (Right to Buy)

    2022-10-27+865865 total
    Exercise: $295.77Exp: 2032-10-27Common Stock (865 underlying)
Holdings
  • Stock Options (Right to Buy)

    Exercise: $255.69From: 2021-10-28Exp: 2030-10-29Common Stock (1,507 underlying)
    1,507
  • Stock Options (Right to Buy)

    Exercise: $278.87From: 2021-10-29Exp: 2030-07-31Common Stock (361 underlying)
    361
  • Stock Options (Right to Buy)

    Exercise: $515.24From: 2022-10-27Exp: 2031-10-28Common Stock (633 underlying)
    633
Footnotes (1)
  • [F1]The option vests on the earlier of the one year anniversary of the grant date (10/27/2022) or the date of Bio-Techne's 2023 annual meeting of shareholders.

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeother

Related Parties

1
  • filerCIK 0001518599

Filing Metadata

Form type
4
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 5:19 PM ET
Size
10.8 KB